Genetic susceptibility to malignant neoplasm of breast
ICD-10 Z15.01 is a billable code used to indicate a diagnosis of genetic susceptibility to malignant neoplasm of breast.
Z15.01 indicates a genetic predisposition to breast cancer, often linked to mutations in genes such as BRCA1 and BRCA2. This code is crucial for identifying patients who may benefit from enhanced screening protocols, preventive measures, and targeted aftercare. Understanding the social determinants of health, such as access to genetic counseling and socioeconomic factors, is essential for comprehensive care. Preventive strategies may include regular mammograms and MRI screenings, while aftercare can involve monitoring and managing the psychological impact of genetic risk. Coders must ensure accurate documentation of family history and genetic testing results to support the use of this code.
Document family history, genetic counseling referrals, and preventive screening plans.
Routine checkups for patients with a family history of breast cancer, referrals for genetic testing, and follow-up on screening results.
Consider social determinants such as access to care, insurance coverage, and patient education on genetic risks.
Population health data on genetic predisposition, screening rates, and outcomes.
Community outreach programs for genetic education, epidemiological studies on breast cancer incidence.
Focus on health disparities and access to genetic testing in underserved populations.
Used for patients with a family history of breast cancer to assess genetic risk.
Document the reason for testing, family history, and results.
Primary care providers should coordinate with genetic counselors for comprehensive care.
Ordered for patients with genetic susceptibility to monitor for breast cancer.
Indicate the need for MRI based on genetic risk factors.
Ensure proper referral and follow-up for results.
Z15.01 should be used when a patient has a documented genetic susceptibility to breast cancer, particularly after genetic testing has confirmed a mutation. It is essential to link this code with preventive screenings and aftercare to ensure comprehensive patient management.
